Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Citation
The Other Blumenthal Scandal
Op-Eds
Off Target On Off-Label Drugs
Americans are becoming increasingly dissatisfied with their government, according to opinion polls released in April by the Pew Research Center. The center’s president, Andrew…
Newsletter
GM’s Misleading Bailout Claims, Swine Flu and Financial “Reform” Legislation
General Motors boasts that it has repaid its government loans in full, despite having used other bailout funds to repay the initial loans. The government…
Newsletter
Pesticides, Communication Privacy and Climategate’s Impact
The Environmental Protection Agency proposes incorrectly labeling new biotech fruit as containing pesticides. The Federal Energy Regulatory Commission requires employees to keep records of their…
Comment
CEI Comments on EPA Biopesticides Registration for Biotech Plum
Full Document Available in PDF The Competitive Enterprise Institute (CEI) appreciates…
News Release
EPA May Force Pesticide Label on New Biotech Fruit
Washington, D.C., April 30, 2010 – The Competitive Enterprise Institute today condemned a proposed Environmental Protection Agency action plan that would, for the first…